Results
|
1261.
|
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis. [electronic resource] by
- Naegelin, Y
- Rasenack, M
- Andelova, M
- Von Felten, S
- Fischer-Barnicol, B
- Amann, M
- Mehling, M
- Kappos, L
- Sprenger, T
- Derfuss, T
Producer: 20181213
In:
Multiple sclerosis and related disorders vol. 25
Availability: No items available.
|
|
1262.
|
|
|
1263.
|
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis. [electronic resource] by
- Boz, Cavit
- Terzi, Murat
- Özer, Bilge
- Turkoglu, Recai
- Karabudak, Rana
- Efendi, Hüsnü
- Soysal, Aysun
- Sevim, Serhan
- Altintas, Ayse
- Kurne, Asli
- Akçalı, Aylin
- Akman, Gülsen
- Yüceyar, Nur
- Balcı, Belgin Petek
- Ekmekci, Özgul
- Karahan, Serap Zengin
- Demirkıran, Meltem
- Altunrende, Burcu
- Turan, Ömer Faruk
- Kale, Nilüfer
- Köseoğlu, Mesrure
- Ozakbas, Serkan
Producer: 20200519
In:
Multiple sclerosis and related disorders vol. 36
Availability: No items available.
|
|
1264.
|
|
|
1265.
|
|
|
1266.
|
|
|
1267.
|
|
|
1268.
|
Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. [electronic resource] by
- Allende, Maria L
- Sasaki, Teiji
- Kawai, Hiromichi
- Olivera, Ana
- Mi, Yide
- van Echten-Deckert, Gerhild
- Hajdu, Richard
- Rosenbach, Mark
- Keohane, Carol Ann
- Mandala, Suzanne
- Spiegel, Sarah
- Proia, Richard L
Producer: 20050201
In:
The Journal of biological chemistry vol. 279
Availability: No items available.
|
|
1269.
|
|
|
1270.
|
|
|
1271.
|
|
|
1272.
|
|
|
1273.
|
|
|
1274.
|
|
|
1275.
|
|
|
1276.
|
|
|
1277.
|
|
|
1278.
|
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. [electronic resource] by
- Kalincik, Tomas
- Brown, J William L
- Robertson, Neil
- Willis, Mark
- Scolding, Neil
- Rice, Claire M
- Wilkins, Alastair
- Pearson, Owen
- Ziemssen, Tjalf
- Hutchinson, Michael
- McGuigan, Christopher
- Jokubaitis, Vilija
- Spelman, Tim
- Horakova, Dana
- Havrdova, Eva
- Trojano, Maria
- Izquierdo, Guillermo
- Lugaresi, Alessandra
- Prat, Alexandre
- Girard, Marc
- Duquette, Pierre
- Grammond, Pierre
- Alroughani, Raed
- Pucci, Eugenio
- Sola, Patrizia
- Hupperts, Raymond
- Lechner-Scott, Jeannette
- Terzi, Murat
- Van Pesch, Vincent
- Rozsa, Csilla
- Grand'Maison, François
- Boz, Cavit
- Granella, Franco
- Slee, Mark
- Spitaleri, Daniele
- Olascoaga, Javier
- Bergamaschi, Roberto
- Verheul, Freek
- Vucic, Steve
- McCombe, Pamela
- Hodgkinson, Suzanne
- Sanchez-Menoyo, Jose Luis
- Ampapa, Radek
- Simo, Magdolna
- Csepany, Tunde
- Ramo, Cristina
- Cristiano, Edgardo
- Barnett, Michael
- Butzkueven, Helmut
- Coles, Alasdair
Producer: 20170606
In:
The Lancet. Neurology vol. 16
Availability: No items available.
|
|
1279.
|
|
|
1280.
|
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. [electronic resource] by
- Chitnis, Tanuja
- Arnold, Douglas L
- Banwell, Brenda
- Brück, Wolfgang
- Ghezzi, Angelo
- Giovannoni, Gavin
- Greenberg, Benjamin
- Krupp, Lauren
- Rostásy, Kevin
- Tardieu, Marc
- Waubant, Emmanuelle
- Wolinsky, Jerry S
- Bar-Or, Amit
- Stites, Tracy
- Chen, Yu
- Putzki, Norman
- Merschhemke, Martin
- Gärtner, Jutta
Producer: 20180921
In:
The New England journal of medicine vol. 379
Availability: No items available.
|